One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease

Chinese Medical Journal

Volumn 119, Issue 2, 2006, Pages 165-168

  Zhang, Qi ^a   Zhang, Rui Yan ^a   Zhang, Jian Sheng ^a   Hu, Jian ^a   Yang, Zhen Kun ^a   Ni, Jun ^a   Fang, Yue Hua ^a   Zhang, Xian ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Coronary artery disease; Restenosis; Sirolimus; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; POLYMER; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE THROMBOSIS; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; MIDDLE AGED; STENT; THROMBOSIS;

ADULT; AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; STENTS; THROMBOSIS;

EID: 33644983947     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200601020-00013     Document Type: Article

References (13)

1. Homes DR, Leon MB, Moses JW, Popma JJ, Fitzgerald PJ, Brown C, at al. Analysis of 1 -year clinical outcomes in the SIRIUS trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-640.
2. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoya A, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109:190-195.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
4. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109:1942-1947.
5. Zhang Q, Shen WF, Zhang JS, Zhang RY, Hu J, Yang ZK, et al. Early and short-term clinical outcome of ACS MULTI-LINK PENTA coronary stent implantation. J Intervent Radiol (Chin) 2002; 11: 419-420.
6. Smith SC Jr, Dove JT Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention (revised of the 1993 PTCA guidelines). J Am Coll Cardiol 2001; 37: 2215-2239.
7. Moses JW, Leon MB, Popma JJ, Fitzgerakd PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
8. Simonton CA, Brodie BR, Wilson BH. Drug-eluting stents for emerging treatment strategies in complex lesions. Rev Cardiovasc Med 2005; 6 Suppl 1: s38-s47.
9. Shafiq N, Malhotra S, Pandhi P, Grover A, Uboweja A. A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol 2005; 59: 94-101.
10. Ong ATL, Serruys PW, Aoki J, Hoya A, van Mieghem AG, Rodriguez-Granillo GA, et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-stent evaluated at Rotterdam Cardiology Hospital (T-RESEARCH) registry. J Am Coll Cardiol 2005; 45: 1135-1141.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
12. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
13. lakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.